Citations (383)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Ruben P.A. van Eijk, Tessa Kliest, Christopher J. McDermott, Kit C.B. Roes, Philip Van Damme, Adriano Chio, Markus Weber, Caroline Ingre, Philippe Corcia, Mònica Povedano, Evy Reviers, Michael A. van Es, Ammar Al-Chalabi, Orla Hardiman & Leonard H. van den Berg. (2020) TRICALS: creating a highway toward a cure. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 496-501.
Read now
Read now
Cristian Ricci, Jeannine Baumgartner, Linda Malan & Cornelius M. Smuts. (2020) Determining sample size adequacy for animal model studies in nutrition research: limits and ethical challenges of ordinary power calculation procedures. International Journal of Food Sciences and Nutrition 71:2, pages 256-264.
Read now
Read now
Marion C. Hogg, Luise Halang, Ina Woods, Karen S. Coughlan & Jochen H. M. PREHN. (2018) Riluzole does not improve lifespan or motor function in three ALS mouse models. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 438-445.
Read now
Read now
Svitlana Garbuzova-Davis, Avery Thomson, Crupa Kurien, R. Douglas Shytle & Paul R. Sanberg. (2016) Potential new complication in drug therapy development for amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 16:12, pages 1397-1405.
Read now
Read now
Kevin S. S. Henning & Peter H. Westfall. (2015) Closed Testing in Pharmaceutical Research: Historical and Recent Developments. Statistics in Biopharmaceutical Research 7:2, pages 126-147.
Read now
Read now
Matthew D. Figley & Aaron D. Gitler. (2013) Yeast genetic screen reveals novel therapeutic strategy for ALS. Rare Diseases 1:1.
Read now
Read now
Stefanie Saenger, Bettina Holtmann, Mark R. Nilges, Susanne Schroeder, Andreas Hoeflich, Heidemarie Kletzl, Will Spooren, Susanne Ostrowitzki, Taleen Hanania, Michael Sendtner & Friedrich Metzger. (2012) Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity. Amyotrophic Lateral Sclerosis 13:5, pages 418-429.
Read now
Read now
. (2011) ALSUntangled 13: Bee Venom. Amyotrophic Lateral Sclerosis 12:6, pages 471-472.
Read now
Read now
Radhia Benmohamed, Anthony C. Arvanites, Jinho Kim, Robert J. Ferrante, Richard B. Silverman, Richard I. Morimoto & Donald R. Kirsch. (2011) Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 12:2, pages 87-96.
Read now
Read now
Albert C. Ludolph, Caterina Bendotti, Eran Blaugrund, Adriano Chio, Linda Greensmith, Jean-Philippe Loeffler, Richard Mead, Heiko G. Niessen, Susanne Petri, Pierre-Francois Pradat, Wim Robberecht, Markus Ruegg, Birgit Schwalenstöcker, Detlev Stiller, Leonard van den Berg, Fernando Vieira & Stephan von Horsten. (2010) Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotrophic Lateral Sclerosis 11:1-2, pages 38-45.
Read now
Read now
Stefano Zoccolella, Andrea Santamato & Paolo Lamberti. (2009) Current and emerging treatments for amyotrophic lateral sclerosis. Neuropsychiatric Disease and Treatment 5, pages 577-595.
Read now
Read now
Hiroko Kishikawa, David Wu & Guo-fu Hu. (2008) Targeting angiogenin in therapy of amyotropic lateral sclerosis. Expert Opinion on Therapeutic Targets 12:10, pages 1229-1242.
Read now
Read now
. (2008) SESSION 6A USE OF THE G93A SOD1 MOUSE IN THERAPEUTIC TESTING. Amyotrophic Lateral Sclerosis 9:sup1, pages 19-20.
Read now
Read now
Veena Lanka & Merit Cudkowicz. (2008) Therapy development for ALS: Lessons learned and path forward. Amyotrophic Lateral Sclerosis 9:3, pages 131-140.
Read now
Read now
Articles from other publishers (369)
Seung Hyun Park, Se Bee Lee, Seoyeon Park, Eun Young Kim, Damiano Pizzol, Mike Trott, Yvonne Barnett, Ai Koyanagi, Louis Jacob, Pinar Soysal, Nicola Veronese, Simona Ippoliti, Ramy Abou Ghayda, Nannan Thirumavalavan, Adonis Hijaz, David Sheyn, Rachel Pope, Britt Conroy, Irina Jaeger, Gupta Shubham, Amihay Nevo, Petre Cristian Ilie, Seung Won Lee, Dong Keon Yon, Hyun Ho Han, Sung Hwi Hong, Jae Il Shin, Lee Ponsky & Lee Smith. (2023) Methodological rigour in preclinical urology: a systematic review reporting research quality over a 14‐year period. BJU International.
Crossref
Crossref
Svitlana Garbuzova-Davis & Cesario V. Borlongan. (2023) Transplanted Human Bone Marrow Endothelial Progenitor Cells Prolong Functional Benefits and Extend Survival of ALS Mice Likely via Blood-Spinal Cord Barrier Repair. Stem Cell Reviews and Reports 19:7, pages 2284-2291.
Crossref
Crossref
Amelia Elaine Cannon, Wolfgang Emanuel Zürrer, Charlotte Zejlon, Zsolt Kulcsar, Sebastian Lewandowski, Fredrik Piehl, Tobias Granberg & Benjamin Victor Ineichen. (2023) Neuroimaging findings in preclinical amyotrophic lateral sclerosis models—How well do they mimic the clinical phenotype? A systematic review. Frontiers in Veterinary Science 10.
Crossref
Crossref
Mahvish Faisal, Jana Aid, Bekzod Nodirov, Benjamin Lee & Miriam A. Hickey. (2023) Preclinical trials in Alzheimer’s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice. PLOS ONE 18:4, pages e0281003.
Crossref
Crossref
Richard J. Mead, Ning Shan, H. Joseph Reiser, Fiona Marshall & Pamela J. Shaw. (2022) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nature Reviews Drug Discovery 22:3, pages 185-212.
Crossref
Crossref
Francesca Sironi, Fabiola De Marchi, Letizia Mazzini & Caterina Bendotti. (2023) Cell therapy in ALS: An update on preclinical and clinical studies. Brain Research Bulletin 194, pages 64-81.
Crossref
Crossref
Rishab Driver & Shweta Mishra. (2022) Organ-On-A-Chip Technology: An In-depth Review of Recent Advancements and Future of Whole Body-on-chip. BioChip Journal 17:1, pages 1-23.
Crossref
Crossref
Zeynep YILDIRIM, Dicle Naz TOKTAŞ, Öznur DEMİR, Zülfiye GÜL & Burcu ŞEN UTSUKARÇİ. (2023) Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi YaklaşımlarıAn Evaluation of Amyotrophic Lateral Sclerosis and Current Situation in Its Treatment. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Laura M. Cox, Narghes Calcagno, Christian Gauthier, Charlotte Madore, Oleg Butovsky & Howard L. Weiner. (2022) The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome 10:1.
Crossref
Crossref
Maria Victoria Humbert, Cosma Mirella Spalluto, Joseph Bell, Cornelia Blume, Franco Conforti, Elizabeth R. Davies, Lareb S.N. Dean, Paul Elkington, Hans Michael Haitchi, Claire Jackson, Mark G. Jones, Matthew Loxham, Jane S. Lucas, Hywel Morgan, Marta Polak, Karl J. Staples, Emily J. Swindle, Liku Tezera, Alastair Watson & Tom M.A. Wilkinson. (2022) Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding. European Respiratory Journal 60:6, pages 2200455.
Crossref
Crossref
Sherif M. Elbasiouny. (2022) Motoneuron excitability dysfunction in ALS: Pseudo‐mystery or authentic conundrum?. The Journal of Physiology 600:22, pages 4815-4825.
Crossref
Crossref
Devendra Singh, Himika Wasan & K. H. Reeta. (2021) Preclinical Stroke Research and Translational Failure: A Bird’s Eye View on Preventable Variables. Cellular and Molecular Neurobiology 42:7, pages 2003-2017.
Crossref
Crossref
Mohammed Khamaysa & Pierre-François Pradat. (2022) Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas. Journal of Personalized Medicine 12:10, pages 1601.
Crossref
Crossref
Taide Wang, Doris Tomas, Nirma D. Perera, Brittany Cuic, Sophia Luikinga, Aida Viden, Samantha K. Barton, Catriona A. McLean, André L. Samson, Adam Southon, Ashley I. Bush, James M. Murphy & Bradley J. Turner. (2021) Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis. Cell Death & Differentiation 29:6, pages 1187-1198.
Crossref
Crossref
Barış Genç, Mukesh Gautam, Benjamin R. Helmold, Nuran Koçak, Aksu Günay, Gashaw M. Goshu, Richard B. Silverman & P. Hande Ozdinler. (2022) NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone. Scientific Reports 12:1.
Crossref
Crossref
Caterina Peggion, Valeria Scalcon, Maria Lina Massimino, Kelly Nies, Raffaele Lopreiato, Maria Pia Rigobello & Alessandro Bertoli. (2022) SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells. Antioxidants 11:4, pages 614.
Crossref
Crossref
Penny S. Reynolds. (2022) Between two stools: preclinical research, reproducibility, and statistical design of experiments. BMC Research Notes 15:1.
Crossref
Crossref
Rebecca L. Walker, Katherine W. Saylor, Margaret Waltz & Jill A. Fisher. (2021) Translational science: a survey of US biomedical researchers’ perspectives and practices. Lab Animal 51:1, pages 22-35.
Crossref
Crossref
Carolyn Tallon, Anjali Sharma, Zhi Zhang, Ajit G. Thomas, Justin Ng, Xiaolei Zhu, Amanda Donoghue, Michael Schulte, Tawnjerae R. Joe, Siva P. Kambhampati, Rishi Sharma, Kevin Liaw, Sujatha Kannan, Rangaramanujam M. Kannan & Barbara S. Slusher. (2022) Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics 19:1, pages 274-288.
Crossref
Crossref
Megan Dubowsky, Stephanie R Shepheard & Mary-Louise Rogers. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1893
1929
.
Stefan I. McDonough. 2022. Voltage-Gated Calcium Channels. Voltage-Gated Calcium Channels
687
706
.
Megan Dubowsky, Stephanie R Shepheard & Mary-Louise Rogers. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
37
.
Michael MacLean, Judyta Juranek, Swetha Cuddapah, Raquel López-Díez, Henry H. Ruiz, Jiyuan Hu, Laura Frye, Huilin Li, Paul F. Gugger & Ann Marie Schmidt. (2021) Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner. Journal of Neuroinflammation 18:1.
Crossref
Crossref
Alec S. T. Smith, Changho Chun, Jennifer Hesson, Julie Mathieu, Paul N. Valdmanis, David L. Mack, Byung-Ok Choi, Deok-Ho Kim & Mark Bothwell. (2021) Human Induced Pluripotent Stem Cell-Derived TDP-43 Mutant Neurons Exhibit Consistent Functional Phenotypes Across Multiple Gene Edited Lines Despite Transcriptomic and Splicing Discrepancies. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Amanda L. Wright, Paul A. Della Gatta, Sheng Le, Britt A. Berning, Prachi Mehta, Kelly R. Jacobs, Hossai Gul, Rebecca San Gil, Thomas J. Hedl, Winonah R. Riddell, Owen Watson, Sean S. Keating, Juliana Venturato, Roger S. Chung, Julie D. Atkin, Albert Lee, Bingyang Shi, Catherine A. Blizzard, Marco Morsch & Adam K. Walker. (2021) Riluzole does not ameliorate disease caused by cytoplasmic TDP‐43 in a mouse model of amyotrophic lateral sclerosis. European Journal of Neuroscience 54:6, pages 6237-6255.
Crossref
Crossref
Charles V. Vorhees & Michael T. Williams. (2021) Issues in the design, analysis, and application of rodent developmental neurotoxicology studies. Neurotoxicology and Teratology 87, pages 107018.
Crossref
Crossref
J. Jiménez-Villegas, L. Ferraiuolo, R.J. Mead, P.J. Shaw, A. Cuadrado & A.I. Rojo. (2021) NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS. Free Radical Biology and Medicine 173, pages 125-141.
Crossref
Crossref
Amy Keerie, Heledd Brown-Wright, Isaac Kirkland, Andrew Grierson, James J. P. Alix, Christian Holscher & Richard J. Mead. (2021) The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS. Scientific Reports 11:1.
Crossref
Crossref
Jodie A. Watkins, James J. P. Alix, Pamela J. Shaw & Richard J. Mead. (2021) Extensive phenotypic characterisation of a human TDP-43Q331K transgenic mouse model of amyotrophic lateral sclerosis (ALS). Scientific Reports 11:1.
Crossref
Crossref
Katie L. Bailey, Sara B. Cartwright, Neesha S. Patel, Neeley Remmers, Audrey J. Lazenby, Michael A. Hollingsworth & Mark A. Carlson. (2021) Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic. Scientific Reports 11:1.
Crossref
Crossref
Liuji Chen, Ren Na, Kirsten Danae McLane, Cody Sylvester Thompson, Ju Gao, Xinglong Wang & Qitao Ran. (2021) Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Scientific Reports 11:1.
Crossref
Crossref
Yuri Ciervo, Noemi Gatto, Chloe Allen, Andrew Grierson, Laura Ferraiuolo, Richard J. Mead & Pamela J. Shaw. (2021) Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS. Molecular Therapy - Methods & Clinical Development 21, pages 413-433.
Crossref
Crossref
Jian Zhang, Dongxiao Li, Guofeng Yang, Xiangjian Zhang, Lin Chen, Yingzhen Zhang, Xiaoming Qi, Yi Li & Yansu Guo. (2021) Oxymatrine Extends Survival by Attenuating Neuroinflammation in a Mouse Model of Amyotrophic Lateral Sclerosis. Neuroscience 465, pages 11-22.
Crossref
Crossref
Sudheer K. Tungtur, Heather M. Wilkins, Robert S. Rogers, Yomna Badawi, Jessica M. Sage, Abdulbaki Agbas, Omar Jawdat, Richard J. Barohn, Russell H. Swerdlow & Hiroshi Nishimune. (2021) Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord. Scientific Reports 11:1.
Crossref
Crossref
Maria Plesia, Oliver A. Stevens, Gavin R. Lloyd, Catherine A. Kendall, Ian Coldicott, Aneurin J. Kennerley, Gaynor Miller, Pamela J. Shaw, Richard J. Mead, John C. C. Day & James J. P. Alix. (2021)
In Vivo
Fiber Optic Raman Spectroscopy of Muscle in Preclinical Models of Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy
. ACS Chemical Neuroscience 12:10, pages 1768-1776.
Crossref
Crossref
Silvia Scaricamazza, Illari Salvatori, Alberto Ferri & Cristiana Valle. (2021) Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?. Cells 10:3, pages 525.
Crossref
Crossref
Mireia Herrando‐Grabulosa, Núria Gaja‐Capdevila, José M. Vela & Xavier Navarro. (2020) Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis. British Journal of Pharmacology 178:6, pages 1336-1352.
Crossref
Crossref
B. A. Ashford, D. Boche, J. Cooper‐Knock, P. R. Heath, J. E. Simpson & J. R. Highley. (2020) Review: Microglia in motor neuron disease. Neuropathology and Applied Neurobiology 47:2, pages 179-197.
Crossref
Crossref
Barış Genç, Mukesh Gautam, Öge Gözütok, Ina Dervishi, Santana Sanchez, Gashaw M. Goshu, Nuran Koçak, Edward Xie, Richard B. Silverman & P. Hande Özdinler. (2021) Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP‐43 pathology. Clinical and Translational Medicine 11:2.
Crossref
Crossref
Thiago C. Moulin, Laura E. Covill, Pavel M. Itskov, Michael J. Williams & Helgi B. Schiöth. (2021) Rodent and fly models in behavioral neuroscience: An evaluation of methodological advances, comparative research, and future perspectives. Neuroscience & Biobehavioral Reviews 120, pages 1-12.
Crossref
Crossref
Leon M. Tai, Juan Maldonado Weng, Mary Jo LaDu & Scott T. Brady. 2021. Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part B. Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part B
1
48
.
Harald Sontheimer. 2021. Diseases of the Nervous System. Diseases of the Nervous System
135
160
.
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T. Avey, Monya Baker, William J. Browne, Alejandra Clark, Innes C. Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T. Holgate, David W. Howells, Natasha A. Karp, Stanley E. Lazic, Katie Lidster, Catriona J. MacCallum, Malcolm Macleod, Esther J. Pearl, Ole H. Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S. Sena, Shai D. Silberberg, Thomas Steckler & Hanno Würbel. (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. BMC Veterinary Research 16:1.
Crossref
Crossref
Michael R. Strickland, Kristen R. Ibanez, Mariya Yaroshenko, Carolina Ceballos Diaz, David R. Borchelt & Paramita Chakrabarty. (2020) IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis. Scientific Reports 10:1.
Crossref
Crossref
Teresa Cunha-Oliveira, Liliana Montezinho, Catarina Mendes, Omidreza Firuzi, Luciano Saso, Paulo J. Oliveira & Filomena S. G. Silva. (2020) Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity 2020, pages 1-29.
Crossref
Crossref
Sara Nikseresht, James B.W. Hilton, Kai Kysenius, Jeffrey R. Liddell & Peter J. Crouch. (2020) Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond. Life 10:11, pages 271.
Crossref
Crossref
Michael F. W. Festing. (2020) The “completely randomised” and the “randomised block” are the only experimental designs suitable for widespread use in pre-clinical research. Scientific Reports 10:1.
Crossref
Crossref
Takeshi Terabayashi, Gregory G. Germino & Luis F. Menezes. (2020) Pathway identification through transcriptome analysis. Cellular Signalling 74, pages 109701.
Crossref
Crossref
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T. Avey, Monya Baker, William J. Browne, Alejandra Clark, Innes C. Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T. Holgate, David W. Howells, Natasha A. Karp, Stanley E. Lazic, Katie Lidster, Catriona J. MacCallum, Malcolm Macleod, Esther J. Pearl, Ole H. Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S. Sena, Shai D. Silberberg, Thomas Steckler & Hanno Würbel. (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*. Journal of Cerebral Blood Flow & Metabolism 40:9, pages 1769-1777.
Crossref
Crossref
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T. Avey, Monya Baker, William J. Browne, Alejandra Clark, Innes C. Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T. Holgate, David W. Howells, Natasha A. Karp, Stanley E. Lazic, Katie Lidster, Catriona J. MacCallum, Malcolm Macleod, Esther J. Pearl, Ole H. Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S. Sena, Shai D. Silberberg, Thomas Steckler & Hanno Würbel. (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. The Journal of Physiology 598:18, pages 3793-3801.
Crossref
Crossref
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T. Avey, Monya Baker, William J. Browne, Alejandra Clark, Innes C. Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T. Holgate, David W. Howells, Natasha A. Karp, Stanley E. Lazic, Katie Lidster, Catriona J. MacCallum, Malcolm Macleod, Esther J. Pearl, Ole H. Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S. Sena, Shai D. Silberberg, Thomas Steckler & Hanno Würbel. (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Experimental Physiology 105:9, pages 1459-1466.
Crossref
Crossref
Katherine E. A. Lewis, William Bennett, Christopher L. Blizzard, Adrian K. West, Roger S. Chung & Meng Inn Chuah. (2020)
The influence of metallothionein treatment and treadmill running exercise on disease onset and survival in SOD1
G93A
amyotrophic lateral sclerosis mice
. European Journal of Neuroscience 52:4, pages 3223-3241.
Crossref
Crossref
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T. Avey, Monya Baker, William J. Browne, Alejandra Clark, Innes C. Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T. Holgate, David W. Howells, Natasha A. Karp, Stanley E. Lazic, Katie Lidster, Catriona J. MacCallum, Malcolm Macleod, Esther J. Pearl, Ole H. Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S. Sena, Shai D. Silberberg, Thomas Steckler & Hanno Würbel. (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. British Journal of Pharmacology 177:16, pages 3617-3624.
Crossref
Crossref
Yu Zhu, Yue Liu, Fang Yang, Wenzhi Chen, Jianxian Jiang, Pei He, Shishi Jiang, Menhua Li & Renshi Xu. (2020) All-Trans Retinoic Acid Exerts Neuroprotective Effects in Amyotrophic Lateral Sclerosis-Like Tg (SOD1*G93A)1Gur Mice. Molecular Neurobiology 57:8, pages 3603-3615.
Crossref
Crossref
Liping Liu, Kelby M. Killoy, Marcelo R. Vargas, Yasuhiko Yamamoto & Mariana Pehar. (2020)
Effects of RAGE inhibition on the progression of the disease in hSOD1
G93A
ALS mice
. Pharmacology Research & Perspectives 8:4.
Crossref
Crossref
Nathalie Percie du Sert, Amrita Ahluwalia, Sabina Alam, Marc T. Avey, Monya Baker, William J. Browne, Alejandra Clark, Innes C. Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T. Holgate, David W. Howells, Viki Hurst, Natasha A. Karp, Stanley E. Lazic, Katie Lidster, Catriona J. MacCallum, Malcolm Macleod, Esther J. Pearl, Ole H. Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S. Sena, Shai D. Silberberg, Thomas Steckler & Hanno Würbel. (2020) Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biology 18:7, pages e3000411.
Crossref
Crossref
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T. Avey, Monya Baker, William J. Browne, Alejandra Clark, Innes C. Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T. Holgate, David W. Howells, Natasha A. Karp, Stanley E. Lazic, Katie Lidster, Catriona J. MacCallum, Malcolm Macleod, Esther J. Pearl, Ole H. Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S. Sena, Shai D. Silberberg, Thomas Steckler & Hanno Würbel. (2020) The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLOS Biology 18:7, pages e3000410.
Crossref
Crossref
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T Avey, Monya Baker, William J Browne, Alejandra Clark, Innes C Cuthill, Ulrich Dirnagl, Michael Emerson, Paul Garner, Stephen T Holgate, David W Howells, Natasha A Karp, Stanley E Lazic, Katie Lidster, Catriona J MacCallum, Malcolm Macleod, Esther J Pearl, Ole H Petersen, Frances Rawle, Penny Reynolds, Kieron Rooney, Emily S Sena, Shai D Silberberg, Thomas Steckler & Hanno Wuerbel. (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMJ Open Science 4:1, pages e100115.
Crossref
Crossref
Heike J. Wobst, Korrie L. Mack, Dean G. Brown, Nicholas J. Brandon & James Shorter. (2020) The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future. Medicinal Research Reviews 40:4, pages 1352-1384.
Crossref
Crossref
Manoj M. Lalu, Joshua Montroy, Dar Dowlatshahi, Brian Hutton, Pascale Juneau, Neil Wesch, Sarah Y. Zhang, Ryan McGinn, Dale Corbett, Duncan J. Stewart & Dean A. Fergusson. (2019) From the Lab to Patients: a Systematic Review and Meta-Analysis of Mesenchymal Stem Cell Therapy for Stroke. Translational Stroke Research 11:3, pages 345-364.
Crossref
Crossref
Thomas J CunninghamElizabeth Fisher, Pietro Fratta & Jonathan D Gilthorpe. (2020) DNA Editing for Amyotrophic Lateral Sclerosis: Leading Off First Base. The CRISPR Journal 3:2, pages 75-77.
Crossref
Crossref
Diane Ly, Anjila Dongol, Peter Cuthbertson, Thomas V. Guy, Nicholas J. Geraghty, Reece A. Sophocleous, Lucia Sin, Bradley J. Turner, Debbie Watson, Justin J. Yerbury & Ronald Sluyter. (2020) The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice. Purinergic Signalling 16:1, pages 109-122.
Crossref
Crossref
Raffaella Willmann, Joanne Lee, Cathy Turner, Kanneboyina Nagaraju, Annemieke Aartsma-Rus, Dominic J. Wells, Kathryn R. Wagner, Cristina Csimma, Volker Straub, Miranda D. Grounds & Annamaria De Luca. (2020) Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT). Disease Models & Mechanisms 13:2.
Crossref
Crossref
Kleber Neves, Clarissa FD Carneiro, Ana Paula Wasilewska-Sampaio, Mariana Abreu, Bruna Valério-Gomes, Pedro B Tan & Olavo B Amaral. (2020) Two years into the Brazilian Reproducibility Initiative: reflections on conducting a large-scale replication of Brazilian biomedical science. Memórias do Instituto Oswaldo Cruz 115.
Crossref
Crossref
Manoj M. Lalu, Joshua Montroy, C. Glenn Begley, Tania Bubela, Victoria Hunniford, David Ripsman, Neil Wesch, Jonathan Kimmelman, Malcolm Macleod, David Moher, Alvin Tieu, Lindsey Sikora & Dean A. Fergusson. (2020) Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol. F1000Research 9, pages 485.
Crossref
Crossref
Manoj M. Lalu, Joshua Montroy, C. Glenn Begley, Tania Bubela, Victoria Hunniford, David Ripsman, Neil Wesch, Jonathan Kimmelman, Malcolm Macleod, David Moher, Alvin Tieu, Lindsey Sikora & Dean A. Fergusson. (2020) Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol. F1000Research 9, pages 485.
Crossref
Crossref
Charles V. Vorhees & Michael T. Williams. (2020) Litter effects: Comments on Golub and Sobin's “Statistical modeling of litter as a random effect in mixed models to manage “intralitter likeness””. Neurotoxicology and Teratology 77, pages 106852.
Crossref
Crossref
Sarah K. Gross, Bo Sung Shim, Raymond T. Bartus, Dan Deaver, Zachary McEachin, Alexandre Bétourné, Nicholas M. Boulis & Nicholas J. Maragakis. (2020) Focal and dose-dependent neuroprotection in ALS mice following AAV2-neurturin delivery. Experimental Neurology 323, pages 113091.
Crossref
Crossref
Gerd Bode & Petra Starck-Lantova. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1145
1168
.
Pandora Pound. 2020. Neuroethics and Nonhuman Animals. Neuroethics and Nonhuman Animals
287
302
.
Caroline J. Zeiss, Dongwook Shin, Brent Vander Wyk, Amanda P. Beck, Natalie Zatz, Charles A. Sneiderman & Halil Kilicoglu. (2019) Menagerie: A text-mining tool to support animal-human translation in neurodegeneration research. PLOS ONE 14:12, pages e0226176.
Crossref
Crossref
John D. Lee, Ning Liu, Samantha C. Levin, Lars Ottosson, Ulf Andersson, Helena E. Harris & Trent M. Woodruff. (2019) Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Neuroinflammation 16:1.
Crossref
Crossref
Pieter H. Bos, Emily R. Lowry, Jonathon Costa, Sebastian Thams, Alejandro Garcia-Diaz, Arie Zask, Hynek Wichterle & Brent R. Stockwell. (2019) Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents. Cell Chemical Biology 26:12, pages 1703-1715.e37.
Crossref
Crossref
David I. Lewis. (2019) Animal experimentation: implementation and application of the 3Rs. Emerging Topics in Life Sciences 3:6, pages 675-679.
Crossref
Crossref
Natasha A Karp & Neil Reavey. (2018) Sex bias in preclinical research and an exploration of how to change the status quo. British Journal of Pharmacology 176:21, pages 4107-4118.
Crossref
Crossref
Joana G Fernandes, Nuno H Franco, Andrew J Grierson, Jan Hultgren, Andrew J W Furley & I Anna S Olsson. (2019) Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review. BMJ Open Science 3:1, pages e000016.
Crossref
Crossref
Ying-Tsen Tung, Kuan-Chih Peng, Yen-Chung Chen, Ya-Ping Yen, Mien Chang, Sebastian Thams & Jun-An Chen. (2019) Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration. Cell Stem Cell 25:2, pages 193-209.e7.
Crossref
Crossref
Zoë P. Van Acker, Ken Declerck, Evi Luyckx, Wim Vanden Berghe & Sylvia Dewilde. (2019) Non-Methylation-Linked Mechanism of REST-Induced Neuroglobin Expression Impacts Mitochondrial Phenotypes in a Mouse Model of Amyotrophic Lateral Sclerosis. Neuroscience 412, pages 233-247.
Crossref
Crossref
Jhan-Jie Peng, Shih-Han Lin, Yu-Tzu Liu, Hsin-Chieh Lin, Tsai-Ning Li & Chi-Kuang Yao. (2019) A circuit-dependent ROS feedback loop mediates glutamate excitotoxicity to sculpt the Drosophila motor system. eLife 8.
Crossref
Crossref
Yulia Dzhashiashvili, Chase P. Monckton, Harini S. Shah, Rejani B. Kunjamma & Brian Popko. (2019) The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS. Neurobiology of Disease 127, pages 527-544.
Crossref
Crossref
Hwa Jin Jung, Kwang-Pyo Lee, Ki-Sun Kwon & Yousin Suh. (2019) MicroRNAs in Skeletal Muscle Aging: Current Issues and Perspectives. The Journals of Gerontology: Series A 74:7, pages 1008-1014.
Crossref
Crossref
Prashant Bharadwaj. 2019. Neurodegeneration and Alzheimer's Disease. Neurodegeneration and Alzheimer's Disease
291
310
.
Victoria M. McLeod, Chew L. Lau, Mathew D.F. Chiam, Thusitha W. Rupasinghe, Ute Roessner, Elvan Djouma, Wah C. Boon & Bradley J. Turner. (2019)
Androgen receptor antagonism accelerates disease onset in the SOD1
G93A
mouse model of amyotrophic lateral sclerosis
. British Journal of Pharmacology.
Crossref
Crossref
Elizabeth M. C. FisherDavid M. Bannerman. (2019) Mouse models of neurodegeneration: Know your question, know your mouse. Science Translational Medicine 11:493.
Crossref
Crossref
Raeesa Gupte, Sarah Christian, Paul Keselman, Joshua Habiger, William M. Brooks & Janna L. Harris. (2018) Evaluation of taurine neuroprotection in aged rats with traumatic brain injury. Brain Imaging and Behavior 13:2, pages 461-471.
Crossref
Crossref
Katie L. Bailey & Mark A. Carlson. (2019) Porcine Models of Pancreatic Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Emiliano Biasini. (2019) A designer chaperone against prion diseases. Nature Biomedical Engineering 3:3, pages 167-168.
Crossref
Crossref
Ravinder Malik, Helen Meng, Piriya Wongkongkathep, Christian I. Corrales, Niki Sepanj, Ryan S. Atlasi, Frank-Gerrit Klärner, Thomas Schrader, Melissa J. Spencer, Joseph A. Loo, Martina Wiedau & Gal Bitan. (2019) The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS. Journal of Biological Chemistry 294:10, pages 3501-3513.
Crossref
Crossref
Kevin Mullane & Michael Williams. (2019) Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity. Current Protocols in Pharmacology 84:1, pages e57.
Crossref
Crossref
. (2019) Did a change in Nature journals’ editorial policy for life sciences research improve reporting?. BMJ Open Science 3:1, pages e000035.
Crossref
Crossref
Marta Rigoli, Giovanni Spagnolli, Pietro Faccioli, Jesús R Requena & Emiliano Biasini. (2019) Ok Google, how could I design therapeutics against prion diseases?. Current Opinion in Pharmacology 44, pages 39-45.
Crossref
Crossref
Arpan R Mehta, Rachel Walters, Fergal M Waldron, Suvankar Pal, Bhuvaneish T Selvaraj, Malcolm R Macleod, Giles E Hardingham, Siddharthan Chandran & Jenna M Gregory. (2019) Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Brain Communications 1:1.
Crossref
Crossref
. 2019. Reproducibility in Biomedical Research. Reproducibility in Biomedical Research
313
324
.
Gerd Bode & Petra Starck-Lantova. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
24
.
Paul Moser. 2020. Good Research Practice in Non-Clinical Pharmacology and Biomedicine. Good Research Practice in Non-Clinical Pharmacology and Biomedicine
101
117
.
Isabel A. Lefevre & Rita J. Balice-Gordon. 2020. Good Research Practice in Non-Clinical Pharmacology and Biomedicine. Good Research Practice in Non-Clinical Pharmacology and Biomedicine
35
54
.
Miles S. Lyon, Marlena Wosiski-Kuhn, Rachel Gillespie, James Caress & Carol Milligan. (2019) Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle & Nerve 59:1, pages 10-22.
Crossref
Crossref
Michal Izrael, Shalom Guy Slutsky, Tamar Admoni, Louisa Cohen, Avital Granit, Arik Hasson, Joseph Itskovitz-Eldor, Lena Krush Paker, Graciela Kuperstein, Neta Lavon, Shiran Yehezkel Ionescu, Leonardo Javier Solmesky, Rachel Zaguri, Alina Zhuravlev, Ella Volman, Judith Chebath & Michel Revel. (2018) Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models. Stem Cell Research & Therapy 9:1.
Crossref
Crossref
Amaya Rando, Diego Pastor, Mari Carmen Viso-León, Anna Martínez, Raquel Manzano, Xavier Navarro, Rosario Osta & Salvador Martínez. (2018) Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease. Stem Cell Research & Therapy 9:1.
Crossref
Crossref
W.M.F. Rêgo, J.G.L. Costa, R.C.A. Baraviera, L.V. Pinto, G.L. Bessa, R.E.N. Lopes, J.A.G. Silveira & R.W.A. Vitor. (2018) Genetic diversity of Toxoplasma gondii isolates obtained from free-living wild birds rescued in Southeastern Brazil. International Journal for Parasitology: Parasites and Wildlife 7:3, pages 432-438.
Crossref
Crossref
Bonnie Quach, Trine Krogh-Madsen, Emilia Entcheva & David J. Christini. (2018) Light-Activated Dynamic Clamp Using iPSC-Derived Cardiomyocytes. Biophysical Journal 115:11, pages 2206-2217.
Crossref
Crossref
Albino Maggio, Ray Bressan, Yang Zhao, Junghoon Park & Dae-Jin Yun. (2018) It’s Hard to Avoid Avoidance: Uncoupling the Evolutionary Connection between Plant Growth, Productivity and Stress “Tolerance”. International Journal of Molecular Sciences 19:11, pages 3671.
Crossref
Crossref
E. Andrew Balas. 2018. Innovative Research in Life Sciences. Innovative Research in Life Sciences
89
107
.
E. Andrew Balas. 2018. Innovative Research in Life Sciences. Innovative Research in Life Sciences
37
52
.
Holger Langhof, William Wei Lim Chin, Susanne Wieschowski, Carole Federico, Jonathan Kimmelman & Daniel Strech. (2018) Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study. British Journal of Pharmacology 175:22, pages 4229-4238.
Crossref
Crossref
S. Lehmann, E. Esch, P. Hartmann, A. Goswami, S. Nikolin, J. Weis, C. Beyer & S. Johann. (2018)
Expression profile of pattern recognition receptors in skeletal muscle of SOD1
(G93A)
amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients
. Neuropathology and Applied Neurobiology 44:6, pages 606-627.
Crossref
Crossref
J. A. Clark, C. A. Blizzard, M. C. Breslin, E. J. Yeaman, K. M. Lee, J. A. Chuckowree & T. C. Dickson. (2018)
Epothilone D accelerates disease progression in the SOD1
G93A
mouse model of amyotrophic lateral sclerosis
. Neuropathology and Applied Neurobiology 44:6, pages 590-605.
Crossref
Crossref
Ted M. Dawson, Todd E. Golde & Clotilde Lagier-Tourenne. (2018) Animal models of neurodegenerative diseases. Nature Neuroscience 21:10, pages 1370-1379.
Crossref
Crossref
Michael FW Festing. (2018) On determining sample size in experiments involving laboratory animals. Laboratory Animals 52:4, pages 341-350.
Crossref
Crossref
Cathleen Lutz. (2018) Mouse models of ALS: Past, present and future. Brain Research 1693, pages 1-10.
Crossref
Crossref
Mehdi Ghasemi & Robert H. BrownJr.Jr.. (2018) Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harbor Perspectives in Medicine 8:5, pages a024125.
Crossref
Crossref
Clarissa F. D. Carneiro, Thiago C. Moulin, Malcolm R. Macleod & Olavo B. Amaral. (2018) Effect size and statistical power in the rodent fear conditioning literature – A systematic review. PLOS ONE 13:4, pages e0196258.
Crossref
Crossref
Elizabeth M. Berry-Kravis, Lothar Lindemann, Aia E. Jønch, George Apostol, Mark F. Bear, Randall L. Carpenter, Jacqueline N. Crawley, Aurore Curie, Vincent Des Portes, Farah Hossain, Fabrizio Gasparini, Baltazar Gomez-Mancilla, David Hessl, Eva Loth, Sebastian H. Scharf, Paul P. Wang, Florian Von Raison, Randi Hagerman, Will Spooren & Sébastien Jacquemont. (2017) Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews Drug Discovery 17:4, pages 280-299.
Crossref
Crossref
Anton Bespalov & Thomas Steckler. (2018) Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?. Journal of Neuroscience Methods 300, pages 4-9.
Crossref
Crossref
Sebastiano Giuseppe Crisafulli, Simona Brajkovic, Maria Sara Cipolat Mis, Valeria Parente & Stefania Corti. (2017) Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis. Molecular Neurobiology 55:4, pages 2789-2813.
Crossref
Crossref
Björn Brembs. (2018) Prestigious Science Journals Struggle to Reach Even Average Reliability. Frontiers in Human Neuroscience 12.
Crossref
Crossref
Nazanin R. Kondori, Praveen Paul, Jacqueline P. Robbins, Ke Liu, John C. W. Hildyard, Dominic J. Wells & Jacqueline S. de Belleroche. (2018) Focus on the Role of D-serine and D-amino Acid Oxidase in Amyotrophic Lateral Sclerosis/Motor Neuron Disease (ALS). Frontiers in Molecular Biosciences 5.
Crossref
Crossref
Teresia M. Osborn, Jonathan Beagan & Ole Isacson. (2018) Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression. Neurobiology of Disease 110, pages 218-230.
Crossref
Crossref
Alexandre Henriques, Vincent Croixmarie, Alexandra Bouscary, Althéa Mosbach, Céline Keime, Claire Boursier-Neyret, Bernard Walter, Michael Spedding & Jean-Philippe Loeffler. (2018) Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Maria E. Sheean, Violeta Stoyanova-Beninska, Giuseppe Capovilla, Dinah Duarte, Matthias P. Hofer, Michel Hoffmann, Armando Magrelli, Segundo Mariz, Stelios Tsigkos, Evyenia Shaili, Benedetta Polsinelli, Mario Ricciardi, Milton Bonelli, Pavel Balabanov, Kristina Larsson & Bruno Sepodes. (2018) Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions. Drug Discovery Today 23:1, pages 26-48.
Crossref
Crossref
Kevin Mullane, Michael J. Curtis & Michael Williams. 2018. Research in the Biomedical Sciences. Research in the Biomedical Sciences
1
66
.
Gerd Bode & Petra Starck-Lantova. 2018. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
24
.
Michael F. W. Festing. 2018. Pre-Clinical and Clinical Methods in Brain Trauma Research. Pre-Clinical and Clinical Methods in Brain Trauma Research
201
225
.
Andrew P. Tosolini & James N. Sleigh. (2017) Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Nazanin Rahmani Kondori, Praveen Paul, Jacqueline P. Robbins, Ke Liu, John C. W. Hildyard, Dominic J. Wells & Jacqueline S. de Belleroche. (2017) Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons. PLOS ONE 12:12, pages e0188912.
Crossref
Crossref
Andrew B. West. (2017) Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease. Experimental Neurology 298, pages 236-245.
Crossref
Crossref
Marius Heitzer, Sarah Kaiser, Mithila Kanagaratnam, Adib Zendedel, Philipp Hartmann, Cordian Beyer & Sonja Johann. (2016) Administration of 17β-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice. Molecular Neurobiology 54:10, pages 8429-8443.
Crossref
Crossref
Maria A. Lim, Brenton Louie, Daniel Ford, Kyle Heath, Paulyn Cha, Joe Betts-Lacroix, Pek Yee Lum, Timothy L. Robertson & Laura Schaevitz. (2017) Development of the Digital Arthritis Index, a Novel Metric to Measure Disease Parameters in a Rat Model of Rheumatoid Arthritis. Frontiers in Pharmacology 8.
Crossref
Crossref
W.M.F. Rêgo, J.G.L. Costa, R.C.A. Baraviera, L.V. Pinto, G.L. Bessa, R.E.N. Lopes & R.W.A. Vitor. (2017) Association of ROP18 and ROP5 was efficient as a marker of virulence in atypical isolates of Toxoplasma gondii obtained from pigs and goats in Piauí, Brazil. Veterinary Parasitology 247, pages 19-25.
Crossref
Crossref
Giuliana Castello Coatti, Miriam Frangini, Marcos C. Valadares, Juliana Plat Gomes, Natalia O. Lima, Natale Cavaçana, Amanda F. Assoni, Mayra V. Pelatti, Alexander Birbrair, Antonio Carlos Pedroso de Lima, Julio M. Singer, Francisco Marcelo M. Rocha, Giovani Loiola Da Silva, Mario Sergio Mantovani, Lucia Inês Macedo-Souza, Merari F. R. Ferrari & Mayana Zatz. (2017) Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient. Stem Cell Reviews and Reports 13:5, pages 686-698.
Crossref
Crossref
Maria Grazia Biferi, Mathilde Cohen-Tannoudji, Ambra Cappelletto, Benoit Giroux, Marianne Roda, Stéphanie Astord, Thibaut Marais, Corinne Bos, Thomas Voit, Arnaud Ferry & Martine Barkats. (2017) A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model. Molecular Therapy 25:9, pages 2038-2052.
Crossref
Crossref
Claire E. Le Pichon, William J. Meilandt, Sara DominguezHilda SolanoyHan Lin, Hai NguAlvin Gogineni, Arundhati Sengupta GhoshZhiyu JiangSeung-Hye Lee, Janice Maloney, Vineela D. Gandham, Christine D. Pozniak, Bei WangSebum Lee, Michael Siu, Snahel Patel, Zora ModrusanXingrong LiuYork RudhardMiriam Baca, Amy Gustafson, Josh Kaminker, Richard A. D. Carano, Eric J. Huang, Oded ForemanRobby WeimerKimberly Scearce-LevieJoseph W. Lewcock. (2017) Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Science Translational Medicine 9:403.
Crossref
Crossref
Laura M Luh, Indrajit Das & Anne Bertolotti. (2016) qMotor, a set of rules for sensitive, robust and quantitative measurement of motor performance in mice. Nature Protocols 12:7, pages 1451-1457.
Crossref
Crossref
Tomohiro Ohgomori, Ryo Yamasaki, Hideyuki Takeuchi, Kenji Kadomatsu, Jun-ichi Kira & Shozo Jinno. (2017) Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1G93A mouse model of amyotrophic lateral sclerosis. Neuroscience 356, pages 114-124.
Crossref
Crossref
Valentin K. Gribkoff & Leonard K. Kaczmarek. (2017) The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes. Neuropharmacology 120, pages 11-19.
Crossref
Crossref
Roland Patai, Melinda Paizs, Massimo Tortarolo, Caterina Bendotti, Izabella Obál, József I. Engelhardt & László Siklós. (2017) Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:7, pages 1739-1748.
Crossref
Crossref
F. Daniel RamirezPouya MotazedianRichard G. JungPietro Di SantoZachary D. MacDonaldRobert MorelandTrevor SimardAisling A. ClancyJuan J. RussoVivian A. WelchGeorge A. WellsBenjamin Hibbert. (2017) Methodological Rigor in Preclinical Cardiovascular Studies. Circulation Research 120:12, pages 1916-1926.
Crossref
Crossref
Fernando G. Vieira, Theo Hatzipetros, Kenneth Thompson, Andy J. Moreno, Joshua D. Kidd, Valerie R. Tassinari, Beth Levine, Steven Perrin & Alan Gill. (2017) CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Reports 2, pages 47-53.
Crossref
Crossref
Robert A. McArthur. (2017) Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery. Neuroscience & Biobehavioral Reviews 76, pages 4-21.
Crossref
Crossref
John D Lee, Vinod Kumar, Jenny N T Fung, Marc J Ruitenberg, Peter G Noakes & Trent M Woodruff. (2017)
Pharmacological inhibition of complement C5a-C5a
1
receptor signalling ameliorates disease pathology in the hSOD1
G93A
mouse model of amyotrophic lateral sclerosis
. British Journal of Pharmacology 174:8, pages 689-699.
Crossref
Crossref
Jerald Silverman, James Macy & Patricia A Preisig. (2017) The role of the IACUC in ensuring research reproducibility. Lab Animal 46:4, pages 129-135.
Crossref
Crossref
Christopher A. Shaw. 2017. Neural Dynamics of Neurological Disease. Neural Dynamics of Neurological Disease
301
354
.
Daniel J. Holder & Michael J. Marino. (2017) Logical Experimental Design and Execution in the Biomedical Sciences. Current Protocols in Pharmacology 76:1.
Crossref
Crossref
Tesfaye W. Tefera & Karin Borges. (2017) Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Frontiers in Neuroscience 10.
Crossref
Crossref
S. Shekar Dukkipati, Aouatef Chihi, Yiwen Wang & Sherif M. Elbasiouny. (2017) Experimental Design and Data Analysis Issues Contribute to Inconsistent Results of C-Bouton Changes in Amyotrophic Lateral Sclerosis. eneuro 4:1, pages ENEURO.0281-16.2016.
Crossref
Crossref
Andreia Moreira da Silva Santos, John P. Kelly & Karen M. Doyle. (2017) Dose-Dependent Effects of Binge-Like Methamphetamine Dosing on Dopamine and Neurotrophin Levels in Rat Brain. Neuropsychobiology 75:2, pages 63-71.
Crossref
Crossref
Judith A. Hewitt, Liliana L. Brown, Stephanie J. Murphy, Franziska Grieder & Shai D. Silberberg. (2017) Accelerating Biomedical Discoveries through Rigor and Transparency. ILAR Journal 58:1, pages 115-128.
Crossref
Crossref
Caroline J. Zeiss. (2017) From Reproducibility to Translation in Neurodegenerative Disease. ILAR Journal 58:1, pages 106-114.
Crossref
Crossref
Stefanie Rauskolb, Benjamin Dombert & Michael Sendtner. (2017) Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis. Neurobiology of Disease 97, pages 103-113.
Crossref
Crossref
Jodie Stephenson & Sandra Amor. (2017) Modelling amyotrophic lateral sclerosis in mice. Drug Discovery Today: Disease Models 25-26, pages 35-44.
Crossref
Crossref
Genevieve Gowing, Soshana Svendsen & Clive N. Svendsen. 2017. Functional Neural Transplantation IV - Translation to Clinical Application, Part A. Functional Neural Transplantation IV - Translation to Clinical Application, Part A
99
132
.
Katherine S. Button, Liz Bal, Anna Clark & Tim Shipley. (2016) Preventing the ends from justifying the means: withholding results to address publication bias in peer-review. BMC Psychology 4:1.
Crossref
Crossref
Fernanda Gubert, Ana B. Decotelli, Igor Bonacossa-Pereira, Fernanda R. Figueiredo, Camila Zaverucha-do-Valle, Fernanda Tovar-Moll, Luísa Hoffmann, Turan P. Urmenyi, Marcelo F. Santiago & Rosalia Mendez-Otero. (2016) Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis. Stem Cell Research & Therapy 7:1.
Crossref
Crossref
Alexander McGown, Dame Pamela J. Shaw & Tennore Ramesh. (2016) ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis. Molecular Neurodegeneration 11:1.
Crossref
Crossref
Manoj M Lalu, Katrina J Sullivan, Shirley HJ Mei, David Moher, Alexander Straus, Dean A Fergusson, Duncan J Stewart, Mazen Jazi, Malcolm MacLeod, Brent Winston, John Marshall, Brian Hutton, Keith R Walley & Lauralyn McIntyre. (2016) Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial. eLife 5.
Crossref
Crossref
William DeCoteau, Karin L. Heckman, Ana Y. Estevez, Kenneth J. Reed, Wendi Costanzo, David Sandford, Paige Studlack, Jennifer Clauss, Elizabeth Nichols, Jennifer Lipps, Matthew Parker, Bonnie Hays-Erlichman, J.C. Leiter & Joseph S. Erlichman. (2016) Cerium oxide nanoparticles with antioxidant properties ameliorate strength and prolong life in mouse model of amyotrophic lateral sclerosis. Nanomedicine: Nanotechnology, Biology and Medicine 12:8, pages 2311-2320.
Crossref
Crossref
Kelly E. Glajch, Laura Ferraiuolo, Kaly A. Mueller, Matthew J. Stopford, Varsha Prabhkar, Achille Gravanis, Pamela J. Shaw & Ghazaleh Sadri-Vakili. (2016) MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis. PLOS ONE 11:10, pages e0164103.
Crossref
Crossref
Jörg B. Schulz, Mark R. Cookson & Laura Hausmann. (2016) The impact of fraudulent and irreproducible data to the translational research crisis - solutions and implementation. Journal of Neurochemistry 139, pages 253-270.
Crossref
Crossref
Rosa Luisa Potenza, Roberta De Simone, Monica Armida, Valentina Mazziotti, Antonella Pèzzola, Patrizia Popoli & Luisa Minghetti. (2016) Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics 13:4, pages 918-927.
Crossref
Crossref
Ioanna Eleftheriadou, Ioannis Manolaras, Elaine E. Irvine, Michael Dieringer, Antonio Trabalza & Nicholas D. Mazarakis. (2016)
α
CAR IGF-1 vector targeting of motor neurons ameliorates disease progression in ALS mice
. Annals of Clinical and Translational Neurology 3:10, pages 752-768.
Crossref
Crossref
Ari R. Joffe, Meredith Bara, Natalie Anton & Nathan Nobis. (2016) Expectations for the Methodology and Translation of Animal Research: A Survey of the General Public, Medical Students and Animal Researchers in North America. Alternatives to Laboratory Animals 44:4, pages 361-381.
Crossref
Crossref
Minesh Kapadia, Josie Xu & Boris Sakic. (2016) The water maze paradigm in experimental studies of chronic cognitive disorders: Theory, protocols, analysis, and inference. Neuroscience & Biobehavioral Reviews 68, pages 195-217.
Crossref
Crossref
Scott A. Myers, Andrew N. Bankston, Darlene A. Burke, Sujata Saraswat Ohri & Scott R. Whittemore. (2016) Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?. Experimental Neurology 283, pages 560-572.
Crossref
Crossref
Michael F.W. Festing. 2016. Animal Models for Human Cancer. Animal Models for Human Cancer
27
40
.
Andreas Bender & Thomas Klopstock. (2016) Creatine for neuroprotection in neurodegenerative disease: end of story?. Amino Acids 48:8, pages 1929-1940.
Crossref
Crossref
Katherine S. Button. (2016) Statistical Rigor and the Perils of Chance. eneuro 3:4, pages ENEURO.0030-16.2016.
Crossref
Crossref
Anton Bespalov, Thomas Steckler, Bruce Altevogt, Elena Koustova, Phil Skolnick, Daniel Deaver, Mark J. Millan, Jesper F. Bastlund, Dario Doller, Jeffrey Witkin, Paul Moser, Patricio O'Donnell, Ulrich Ebert, Mark A. Geyer, Eric Prinssen, Theresa Ballard & Malcolm Macleod. (2016) Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets. Nature Reviews Drug Discovery 15:7, pages 516-516.
Crossref
Crossref
Jared R. Williams, Emiliano Trias, Pamela R. Beilby, Nathan I. Lopez, Edwin M. Labut, C. Samuel Bradford, Blaine R. Roberts, Erin J. McAllum, Peter J. Crouch, Timothy W. Rhoads, Cliff Pereira, Marjatta Son, Jeffrey L. Elliott, Maria Clara Franco, Alvaro G. Estévez, Luis Barbeito & Joseph S. Beckman. (2016) Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD. Neurobiology of Disease 89, pages 1-9.
Crossref
Crossref
Steve Elliott. (2016) Bad Science: Cause and Consequence. Journal of Pharmaceutical Sciences 105:4, pages 1358-1361.
Crossref
Crossref
Simone J. Jonker, Theo P. Menting, Michiel C. Warlé, Merel Ritskes-Hoitinga & Kimberley E. Wever. (2016) Preclinical Evidence for the Efficacy of Ischemic Postconditioning against Renal Ischemia-Reperfusion Injury, a Systematic Review and Meta-Analysis. PLOS ONE 11:3, pages e0150863.
Crossref
Crossref
Giovanni Nardo, Maria Chiara Trolese, Massimo Tortarolo, Antonio Vallarola, Mattia Freschi, Laura Pasetto, Valentina Bonetto & Caterina Bendotti. (2016) New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models. Brain Pathology 26:2, pages 237-247.
Crossref
Crossref
Diane Moujalled & Anthony R. White. (2016) Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis. CNS Drugs 30:3, pages 227-243.
Crossref
Crossref
Sagit Golko-Perez, Silvia Mandel, Tamar Amit, Lana Kupershmidt, Moussa B. H. Youdim & Orly Weinreb. (2015) Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis. Neurotoxicity Research 29:2, pages 208-217.
Crossref
Crossref
Alec S.T. Smith, Samantha L. Passey, Neil R.W. Martin, Darren J. Player, Vivek Mudera, Linda Greensmith & Mark P. Lewis. (2016) Creating Interactions between Tissue-Engineered Skeletal Muscle and the Peripheral Nervous System. Cells Tissues Organs 202:3-4, pages 143-158.
Crossref
Crossref
Anastasios Fotinos, Yongjin Zhu, Lilly L. J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz & Xin Wang. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
869
903
.
Varan Govind. 2016. Magnetic Resonance Spectroscopy of Degenerative Brain Diseases. Magnetic Resonance Spectroscopy of Degenerative Brain Diseases
121
150
.
Christopher Janus, Carolina Hernandez, Victoria deLelys, Hanno Roder & Hans Welzl. 2016. Mouse Models for Drug Discovery. Mouse Models for Drug Discovery
311
347
.
Michael F. W. Festing. 2016. Mouse Models for Drug Discovery. Mouse Models for Drug Discovery
1
17
.
Mark J Arends, Eric S White & C Bruce A Whitelaw. (2016) Animal and cellular models of human disease. The Journal of Pathology 238:2, pages 137-140.
Crossref
Crossref
Cheryl L Scudamore, Elizabeth J Soilleux, Natasha A Karp, Ken Smith, Richard Poulsom, C Simon Herrington, Michael J Day, Cory F Brayton, Brad Bolon, Bruce Whitelaw, Eric S White, Jeffrey I Everitt & Mark J Arends. (2016) Recommendations for minimum information for publication of experimental pathology data: MINPEPA guidelines. The Journal of Pathology 238:2, pages 359-367.
Crossref
Crossref
Emma Heslop, Cristina Csimma, Volker Straub, John McCall, Kanneboyina Nagaraju, Kathryn R Wagner, Didier Caizergues, Rudolf Korinthenberg, Kevin M Flanigan, Petra Kaufmann, Elizabeth McNeil, Jerry Mendell, Sharon Hesterlee, Dominic J Wells & Kate Bushby. (2015) The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. Orphanet Journal of Rare Diseases 10:1.
Crossref
Crossref
Jia Y Lee, John D Lee, Simon Phipps, Peter G Noakes & Trent M Woodruff. (2015) Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Neuroinflammation 12:1.
Crossref
Crossref
Ari R Joffe, Meredith Bara, Natalie Anton & Nathan Nobis. (2015) Expectations for methodology and translation of animal research: a survey of health care workers. BMC Medical Ethics 16:1.
Crossref
Crossref
Sonja Johann, Marius Heitzer, Mithila Kanagaratnam, Anand Goswami, Tania Rizo, Joachim Weis, Dirk Troost & Cordian Beyer. (2015) NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63:12, pages 2260-2273.
Crossref
Crossref
Christine V. Fontanilla, Huiying Gu, Qingpeng Liu, Timothy Z. Zhu, Changwei Zhou, Brian H. Johnstone, Keith L. March, Robert M. Pascuzzi, Martin R. Farlow & Yansheng Du. (2015) Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis. Scientific Reports 5:1.
Crossref
Crossref
Anna Emde, Chen Eitan, Lee‐Loung Liou, Ryan T Libby, Natali Rivkin, Iddo Magen, Irit Reichenstein, Hagar Oppenheim, Raya Eilam, Aurelio Silvestroni, Betty Alajajian, Iddo Z Ben‐Dov, Julianne Aebischer, Alon Savidor, Yishai Levin, Robert Sons, Scott M Hammond, John M Ravits, Thomas Möller & Eran Hornstein. (2015)
Dysregulated mi
RNA
biogenesis downstream of cellular stress and
ALS
‐causing mutations: a new mechanism for
ALS
. The EMBO Journal 34:21, pages 2633-2651.
Crossref
Crossref
Displaying 200 of 383 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list